Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2016

Mar 17, 2016

30071_dirs_2016-03-17_ac8d061a-89b7-4812-93bc-318a3725b64e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-03-16

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-03-16 ResMed Common Stock A 4680 Acquired 80291 Indirect
2016-03-16 ResMed Common Stock F 2333 Disposed 77958 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 31304 Direct

Footnotes

F1: Shares acquired on vesting of performance-based restricted stock units. The PSUs were granted March 1, 2013, with a three-year performance period. The shares were earned and vested March 16, 2016, when the ResMed compensation committee certified performance.

F2: Shares earned, based on performance, at 40% of the target award.

F3: Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted March 1, 2013.